Uncategorized - January 6, 2025
AUSTIN, TX and DURHAM, NC, Jan. 06, 2025 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company […]
Read More
Uncategorized - January 6, 2025
DETROIT, Jan. 06, 2025 (GLOBE NEWSWIRE) — Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and […]
Read More
Uncategorized - January 6, 2025
CLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end […]
Read More
Uncategorized - January 6, 2025
Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not […]
Read More
Uncategorized - January 6, 2025
– Mollie Leoni, M.D. promoted to Chief Medical Officer – – Francis Burrows, Ph.D. promoted to Chief Scientific Officer – […]
Read More
Uncategorized - January 6, 2025
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president […]
Read More
Uncategorized - January 6, 2025
FRANKLIN, Tenn., Jan. 06, 2025 (GLOBE NEWSWIRE) — Kaiser Aluminum Corporation (NASDAQ: KALU) (“Kaiser” or the “Company”) today announced Jack […]
Read More
Uncategorized - January 6, 2025
WAYNE, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical […]
Read More
Uncategorized - January 6, 2025
NOVATO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development […]
Read More
Uncategorized - January 6, 2025
Dominic Marasco, RPh, joins the company as President, Endocrine Business Unit, effective January 6, 2025 DANBURY, Conn. and WESTLAKE VILLAGE, […]
Read More